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Abstract: It is now well established that noncoding
regulatory variants play a central role in the genetics of
common diseases and in evolution. However, until
recently, we have known little about the mechanisms by
which most regulatory variants act. For instance, what
types of functional elements in DNA, RNA, or proteins are
most often affected by regulatory variants? Which stages
of gene regulation are typically altered? How can we
predict which variants are most likely to impact regulation
in a given cell type? Recent studies, in many cases using
quantitative trait loci (QTL)-mapping approaches in cell
lines or tissue samples, have provided us with consider-
able insight into the properties of genetic loci that have
regulatory roles. Such studies have uncovered novel
biochemical regulatory interactions and led to the
identification of previously unrecognized regulatory
mechanisms. We have learned that genetic variation is
often directly associated with variation in regulatory
activities (namely, we can map regulatory QTLs, not just
expression QTLs [eQTLs]), and we have taken the first
steps towards understanding the causal order of regula-
tory events (for example, the role of pioneer transcription
factors). Yet, in most cases, we still do not know how to
interpret overlapping combinations of regulatory interac-
tions, and we are still far from being able to predict how
variation in regulatory mechanisms is propagated through
a chain of interactions to eventually result in changes in
gene expression profiles.
Introduction
Accumulating evidence indicates that gene regulatory changes
often contribute to species-specific adaptations as well as to within-
species variation in complex phenotypes [1,2], such as interindi-
vidual variation in susceptibility to disease [3–5]. Indeed,
motivated by theoretical arguments regarding the likely functional
importance of variation in gene regulation and the emergence of
genomic technologies that allow one to cheaply and rapidly
characterize regulatory phenotypes, a large number of studies in
the last decade have focused on uncovering the principles of gene
regulation. These studies contributed to a rising recognition that
natural variation in gene regulation may underlie most complex
phenotypes within and between species. We have discovered a
large number of regulatory mechanisms and described in detail
many biochemical interactions that contribute to gene regulation.
This has contributed to a better understanding of how regulatory
information is encoded in the genome, and in a few cases, we have
managed to manipulate gene regulatory programs and thereby
affect complex phenotypes.
Yet, overall, we still have a limited ability to interpret how
genetic variants alter gene regulation. We do not know how to
‘‘read the genome’’ and predict gene regulatory outputs. Our
understanding of regulatory mechanisms and biochemical inter-
actions has not yet matured into an ability to ‘‘read the code’’ and
fully model transcriptional regulation.
Early studies of regulatory variation within and between species
focused on characterizing steady-state mRNA levels, which
represent the output of gene regulatory programs. For example,
genome-wide comparative studies of steady-state mRNA levels
were able to identify a large number of gene expression differences
between species [6,7]. However, while comparative studies
facilitated the identification of interspecies regulatory differences
that may be of functional importance, it was nearly impossible to
pinpoint the genetic changes responsible for these differences.
Thus, such studies had a limited ability to study the underlying
molecular mechanisms of regulatory evolution.
In contrast to early comparative work, studies of mRNA levels
within species were able to take the first steps towards the
characterization of genetic variation in regulatory elements, even
before the development of ultra-high-throughput sequencing
technologies. This was done indirectly, using expression quanti-
tative trait locus (eQTL) mapping to find associations between
genotypes and variation in gene expression levels [8–10]. For most
eQTLs the causal variant was unknown, and even when the likely
causal variant could be inferred with relative confidence, the
regulatory mechanism involved was generally difficult to identify
[11]. Nevertheless, eQTL studies taught us about the spatial
distribution of regulatory variants in the genome [11], the
temporal specificity of the effect of regulatory sequences on
expression patterns (namely, that some regulatory elements only
affect gene expression under certain conditions), and the
magnitude of steady-state expression changes associated with
variation in cis- or trans-regulatory elements [12,13].
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With the rise of massively parallel sequencing technologies, both
comparative studies of gene regulation and studies of regulatory
variation within populations have been able to move beyond
descriptions of steady-state mRNA expression levels [14,15].
Recent studies have characterized interspecies and population-
level variation in multiple aspects of gene regulation, including
chromatin states [16], transcription factor (TF) binding footprints
[17–20], profiles of different epigenetic markers [21–25], and
posttranscriptional modifications [26–30]. These studies have been
able to assess the correlation between variation in different
regulatory mechanisms and variation in mRNA levels, as well as—
using genotype data—infer the likely causal relationship between
genetic variation, changes in regulatory interactions, and differ-
ences in gene expression levels. The combined analyses of data on
multiple types of regulatory mechanisms often allow us to
understand the basis for concerted changes in regulatory outputs,
predict the consequences of a genetic change in regulatory
sequences, and prioritize among statistically equivalent genetic
associations of human diseases. Consequently, more complex
models of regulatory interactions and their effects on gene
expression have been developed.
Recent reviews have discussed the evolution of gene expression
levels [14], the turnover in regulatory elements [31], and the
insights from eQTL mapping studies [4,32]. Here, we review
recent insights into the genetic and mechanistic basis for variation
in gene regulatory phenotypes, focusing especially on human
studies. Our review concentrates on the efforts to perform
combined analyses of multiple types of genomic data to obtain a
more complete picture of the order of causal events that lead to
precise gene regulatory programs. We focus particularly on
mechanisms by which variants affect regulation of nearby genes
(i.e., putatively in cis), as these are better understood and,
moreover, likely represent the first step in most trans-acting QTLs
as well. We examine the emerging models of causal relationships
that explain concerted, or coordinated, changes in regulatory
interactions and point to questions that are still unanswered
regarding combinatorial relationships. Finally, we assess the
proportion of variation in gene expression levels across individuals
that could potentially be explained by variation in the regulatory
mechanisms that have been studied thus far.
Mapping Interindividual Variation in Gene
Expression Levels
A surge of studies over the last few years have used eQTL
mapping to identify substantial numbers of genetic variants
affecting gene expression levels in humans across tissues,
populations, and environmental or cellular conditions. One
attractive property of eQTL mapping is the ability to infer a
direct link between genotypic variation and phenotypic variation,
such as differences in gene expression among individuals. Hence,
eQTL mapping holds great promise as a method to annotate the
function of regulatory loci throughout the genome and potentially
identify causal genetic variants. Even using modest sample sizes
(60–100 individuals), early studies found a large number of genetic
associations with differences in gene regulation, identifying eQTLs
for as many as 30% of genes in lymphoblastoid cell lines (LCLs)
[12,26,33]. More recent studies, with larger sample sizes, have
identified much larger numbers of eQTLs [34–36]. For instance,
using RNA-sequencing-based expression data from whole-blood
samples of 962 individuals, Battle et al. recently identified
proximal (putatively cis-acting) eQTLs within 1 Mb of 78% of
more than 10,000 tested protein-coding genes [36]. Consistent
with earlier reports, the cis eQTLs found by Battle et al. were
enriched near the 59 ends of genes, suggesting that transcriptional
regulation (rather than RNA decay) might be exerting the
strongest amount of control on gene expression levels
[11,26,33,36].
The emerging pattern from recent eQTL studies, with sample
sizes ranging from 1,000 to 5,000 individuals, is that virtually all
expressed genes are likely to have at least one cis-acting eQTL
(which can be detected if the sample size is large enough).
Moreover, recent studies with large sample sizes have also started
to achieve power to reliably identify trans-eQTLs, i.e., variants
that affect the expression of both alleles of a gene; often the
variants and the regulated genes are on different chromosomes
[35,36]. Heritability studies suggest that more than half of the
genetically explained variance in gene expression is due to trans-
acting variants [37], but reliable detection of trans eQTLs has
been challenging in humans because the effect sizes of trans-acting
variants tend to be smaller than for cis eQTLs [35,36] and because
there is a higher statistical penalty for multiple testing. One
promising approach to overcome these issues might be to
specifically focus on QTLs affecting the expression levels of
putative trans-regulatory elements (thereby minimizing the num-
ber of tests performed). For instance, through possible trans-acting
mechanisms that are still unclear, genetic variation affecting long
intergenic noncoding RNAs (lincRNA) regulation could in turn be
influencing the mRNA levels of subsets of protein-coding genes
[38].
Mapping Interindividual Variation in Gene
Regulatory Mechanisms
Despite many attractive properties of the eQTL mapping
approaches, merely mapping a locus associated with gene
expression variation does not provide direct information about
the mechanism perturbed by the associated genetic variant, even if
one assumes that the causal variant has indeed been identified. To
understand which regulatory mechanisms might be affected by
eQTLs, the QTL mapping framework has been extended to
consider a wide variety of genomic assays that relate to aspects of
gene regulation. The rationale is that if an eQTL acts by
perturbing a particular regulatory mechanism—for example, a
histone modification—then the eQTL SNPs should also be
associated with measures of the relevant regulatory mechanism(s).
Such studies, which we will refer to as regulatory QTL (regQTL)
studies, have yielded a number of intriguing insights into the
mechanistic basis for eQTLs specifically and the complex and
combinatorial nature of gene regulatory logic more generally
(Fig. 1).
The paradigm of regQTL mapping has been applied within the
context of numerous mechanisms spanning various stages of
mRNA and protein regulation. The majority of regQTL studies
have been conducted with sample sizes of fewer than 100
individuals, limiting their power to detect trans effects. We will
thus focus on the insights gained from cis-acting regQTL maps.
Moreover, with few notable exceptions [29,30,39], regQTL
studies to date focus on mechanisms that regulate the rate of
transcription and mostly neglect processes of posttranscriptional
RNA processing and degradation. This is consistent with the
prevalent notion that transcriptional mechanisms, as opposed to
RNA decay, exert the largest control on gene expression
phenotypes and might account for most of the observed variation
in steady-state gene expression levels.
The analysis of eQTLs in the context of variation in regulatory
mechanisms has generally involved correlating patterns across
datasets collected from the same samples. This approach considers
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the genetic variation as a foundation for the purpose of inferring
the causal order of events. It is indeed reasonable to assume that
genetic diversity in a locus associated with regulatory variation is
the initial cause for changes in regulatory mechanisms and,
ultimately, in gene expression levels. However, inferring causality
beyond the anchor of genetic diversity is more challenging and is
generally done by identifying shared associations across multiple
regulatory phenotypes. For example, genetic variants associated
with dynamic epigenetic marks such as DNA methylation seem to
contribute modestly to overall gene expression variation [21,40–
42]. In LCLs, an estimated 10%–20% of eQTLs are also classified
as methylation QTLs (meQTLs) [21], and thus it could potentially
be inferred that a small proportion of loci that are affecting gene
expression do so by perturbing DNA methylation levels
[21,40,41].
The inference of causality, however, is problematic. The
intuitive interpretation of a SNP that is deemed to be both an
eQTL and regQTL is that genetic variation at the QTL results in
a change in a regulatory mechanism, which in turn results in a
change of the expression of a nearby gene. Yet, the analysis of
partial correlations across regulatory phenotypes does not gener-
ally indicate a straightforward sequence of molecular events
(Fig. 2). In particular, it would seem that when the effects of
genetic variation are accounted for, changes in gene expression
levels and changes in epigenetic markers (methylation levels or
histone modifications) are often not correlated with each other.
This observation indicates that it is unlikely that there is a direct
causal link between changes in the regulatory mechanism and
differences in gene expression levels. Instead, an additional
regulatory step may underlie the association of both gene
expression and the epigenetic marker with genetic variation at
the QTL.
One explanation for the observation of independent associations
of genetic variation with regulatory marks may involve variation at
TF binding sites. Indeed, variants influencing overall chromatin
accessibility as measured by DNaseI hypersensitivity, which has
long been used as a marker of regulatory activity in general and
TF binding in particular, were found to overlap with as many as
55% of eQTLs in LCLs [19]. A joint analysis of gene expression,
chromatin accessibility, and methylation reveals that DNaseI-
sensitivity QTLs (dsQTLs) that also show significant association
with methylation levels are more likely to be associated with gene
expression changes. This observation may indicate that methyl-
ation, chromatin accessibility, and gene expression levels are either
interacting or are all affected by changes in the same aspect of
regulation—such as TF binding [19].
Changes in transcription factor binding result in changes
to the regulatory landscape
The suggestion that many of the genetic variants associated with
variation in gene expression levels may do so by impacting TF
binding affinity has recently gained some measure of support. A
Fig. 1. A cascade of regulatory mechanisms by which an eQTL SNP can affect gene expression. Studies mapping regulatory QTLs have
identified a variety of mechanisms, many of which are coordinated, by which eQTLs might act to affect variation in mature mRNA levels. First, eQTL
SNPs can impact epigenetic modifications and transcription initiation. These include regulatory processes such as transcription factor binding,
histone modifications, enhancer activity (perhaps mediated by chromatin architecture and conformation), and DNA methylation. Transcriptional
mechanisms, and specifically transcription factor binding, are likely the strongest contributors to variation in steady-state mRNA levels. Second,
recent work has increased appreciation for transcriptional and cotranscriptional processes as major contributors to variation in gene expression levels
and mRNA isoform diversity. These include mechanisms such as transcriptional elongation (by PolII traveling rates), cotranscriptional splicing, and
mRNA processing and modification. Third, eQTL SNPs both within and outside the transcript have been shown to influence posttranscriptional mRNA
processing, which includes mechanisms such as general mRNA degradation, defects in polyadenylation, and targeting by miRNAs. Finally, preliminary
studies have shown that we do not yet fully appreciate the extent to which variation in mRNA expression might impact or even correlate to variation
in downstream protein products, the synthesis of which are additionally regulated by a set of posttranscriptional and translational mechanisms.
doi:10.1371/journal.pgen.1004857.g001
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series of recent studies considered the regulatory impact of histone
modifications, TF binding, and localization of RNA polymerase II
(PolII) in small samples of individuals [16,24,25]. These comple-
mentary studies all found strong allele-specific signatures of PolII
occupancy, histone modifications, and TF binding, consistent with
earlier reports [17,43]. Kasowski et al. used genome-segmentation
methods (based on multiple histone modification profiles [44]) to
understand the genetic basis of chromatin states. They found that
enhancer states (defined primarily by H3K27ac and H3K4me1
histone modifications) exhibit the highest level of variability
between individuals [16]. Yet, most QTLs associated with changes
in enhancer-delineating histone modifications do not correspond
to differences in gene expression levels. This may indicate that
many apparent enhancers are nonfunctional; alternatively, there
might be redundancy in enhancer function, absence of an
intermediate component (such as a chromosome loop colocalizing
the enhancer and promoter), compensatory effects, or buffering of
transcript levels. Yet, it is also possible that interactions between
Fig. 2. An approach for joint quantitative analysis of gene expression and regulatory QTLs. A goal of interindividual studies of regulatory
mechanisms is to understand the extent to which variation at regulatory loci underlies gene expression levels across individuals. (A) This example,
using hypothetical data, shows a QTL that is associated with levels of both DNA methylation in an upstream CpG island (left) and gene expression
(right). Though the example QTL shown here indicates higher DNA methylation due to a G allele (potentially in a CpG pair), SNPs associated with
methylation do not necessarily always fall in CpG dinucleotides. (B) The observed correlation between DNA methylation and gene expression levels
could be due to a few different underlying relationships, two of which we have highlighted here. The extent to which gene expression and regulatory
differences are correlated through an intermediate variable is often tested using an approach called partial correlation analysis. This involves
regressing out the effects of an intermediate variable—genotype in this example—from both DNA methylation and gene expression levels and then
evaluating the residual correlation between the two variables (left). One possibility is that the QTL directly affects differences in DNA methylation,
which then determine (cause) the gene expression level. Thus, gene expression is regulated by the genotype through the DNA methylation effects
(middle), and the residual variance in gene expression levels will still be correlated to residual DNA methylation levels. Alternatively, genotype is
independently associated with both DNA methylation and gene expression levels—for instance, by directly influencing changes in an upstream
mechanism (such as transcription factor binding) that affects DNA methylation and gene expression levels. This would make DNA methylation and
gene expression appear to be correlated, but not causally related (right), and the residual values no longer show any significant correlation.
doi:10.1371/journal.pgen.1004857.g002
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histone modifications, which are implicitly assumed to be
informative under the premise of annotating chromatin states
[45], are less important as causal drivers of variation in gene
expression levels than the marginal effects of either individual
histone modifications or another underlying mechanism.
Kilpinen et al. and McVicker et al. focused more heavily on
understanding the mechanistic basis of QTLs underlying individ-
ual histone modifications. By dissecting the strong links between
histone modification QTLs (many of which regulated multiple
histone modifications in addition to chromatin accessibility), both
studies found that changes in sequence-based affinity for TF
binding underlie a subset of observed changes in histone
modifications and PolII occupancy across individuals (Fig. 3)
[24,25]. These studies propose that in some cases, TF binding is
most likely the first step in a series of events that result in distinct
histone modification profiles and gene expression output. Inter-
estingly, by assaying nascent RNA expression levels in addition to
processed mRNA expression levels, Kilpinen et al. were also able
to observe greater evidence for allele-specific effects in nascent
RNA than in mRNAs [24]. This observation points to additional
and possibly complementary roles of posttranscriptional mecha-
nisms that act in an allele-specific manner to influence steady-state
gene expression levels.
An additional measure of support for the idea that TF binding
may underlie general properties of chromatin states comes from a
study that offered a different perspective on this challenging
problem of inferring causality in the chain of regulatory processes.
White and colleagues [46] used a massively parallel enhancer
assay to test the activity of thousands of sequences. They tested
1,300 genomic sequences that were found, using high-throughput
chromatin immunoprecipitation sequencing (ChIP-seq), to be
bound in mouse retinas by the photoreceptor transcription factor
Cone-rod homeobox (Crx). They also tested 3,000 control
sequences, which were not bound by the TF but contained
similar matches for the known binding motif of the TF. The
enhancer assay was designed to address whether the bound sites
are distinguishable from unbound sites by local primary sequence
features or more influenced by the functional in vivo genomic
context in which motifs reside, namely the chromatin and
epigenetic context. The results were unambiguous: in the vast
majority of cases, the sequence information in segments of just 84
bp centered in individual ChIP-seq peaks was sufficient to
distinguish between bound and unbound sites [46]. These
observations further support the notion that TF binding is
primarily determined by the sequence context and is less driven
by chromatin state. That said, it will be important to repeat these
experiments in more cell types, with more factors, in order to
understand the generality of these results.
The genetic basis of variation in posttranscriptional
regulatory mechanism
There have been far fewer studies that focused on the extent to
which eQTLs are driven by posttranscriptional regulatory
mechanisms, perhaps due to the more complex technical
challenges of assaying posttranscriptional mechanisms on a large
scale. Several studies have mapped the genetic basis of mRNA
splicing variation (splicing QTLs [sQTLs]) and found that much of
the variation in splicing is located within or proximal to the
targeted spliced exon [26,36,47]. As expected, many sQTLs fall
directly within primary splice sites. However, sQTLs also
unexpectedly show a prominent enrichment near transcription
start sites and 59 untranslated regions (UTRs) and within TF
binding sites [36]. This might suggest that splicing mechanisms
could be either independently or concurrently regulating gene
expression through interactions with components of the transcrip-
tional regulatory machinery.
A small number of studies have also investigated the role of
other posttranscriptional mechanisms, such as general RNA decay
(RNA decay [rdQTLs]) [30], alternative polyadenylation [29], and
miRNA binding (miRNA binding QTLs [mirQTLs]) [34,39,48].
Each of these QTL types shows enrichment in 39 UTR motifs or
regulatory elements that have previously been implicated in
transcript stability, such as adenylate-uridylate (AU)-rich elements
and miRNA binding sites [29,30,39]. Interestingly, rdQTLs and
mirQTLs are also often associated with variation in mRNA
expression levels [30,39,48]. SNPs associated with miRNAs tend
to affect miRNA biogenesis rather than target recognition within
the transcript, and stronger regulation by miRNAs is associated
with greater variation in gene expression levels [39]. However, the
picture presented by rdQTLs is more complex, with almost half of
the nearly 200 rdQTLs identified showing counterintuitive
associations with mRNA expression levels (namely, the allele
associated with more rapid RNA decay is also associated with
higher levels of steady-state expression). The mechanisms under-
lying these opposite-direction effects are unclear, but they might
reflect a buffering mechanism or a coupling between transcription
and decay [49]. Overall, it was estimated that as many as 19% of
eQTLs might be driven by differences in mRNA decay [30].
There is still much to be learned about transcriptional and
posttranscriptional mechanisms. Yet, it is also becoming clear
that in order to fully appreciate gene regulatory effects on
human phenotypes, one would have to incorporate studies of
protein expression levels [50–52]. In the first study of its kind in
humans, Wu et al. studied the genetic basis of protein expression
levels in LCLs and the effects of mRNA variation on
downstream protein level phenotypes [50]. They found consid-
erable interindividual variation in protein levels across the 95
LCLs they investigated and were able to identify 77 protein
QTLs (pQTLs). Only about half of these pQTLs were also
found to be affecting transcript levels, which may indicate that
many pQTLs specifically affect the regulation of translation or
protein stability. Perhaps more interesting is the observation
that most (more than 80%) of the eQTL SNPs found in these
LCLs were not also associated with variation in protein levels
[50]. This discrepancy might be partly explained by incomplete
power to detect pQTLs, perhaps due in part to limitations of the
mass spectrometry techniques for protein measurements. Yet,
these observations are also consistent with the results of a recent
comparative proteomics study [53], which found evidence
consistent with buffering or compensation of interspecies
divergence in protein expression levels.
Can we explain variation in gene expression?
Posttranscriptional mechanisms notwithstanding, the available
body of work suggests that variation in steady-state gene
expression levels can disproportionately be explained by variation
in TF binding. In turn, variation in TF binding might underlie
concerted changes in a large number of supporting regulatory
mechanisms that determine chromatin state and accessibility
[19,24,25]. These inferences, based on functional genomic
variation data, are consistent with independently observed
evidence of strong selective pressures on TF binding motifs,
second only to the conservation of protein-coding genes [54]. It
would thus seem that we have made considerable steps towards an
understanding of important properties of gene regulatory logic and
the ability to explain variation in gene expression.
Yet, one ultimate goal of genomics is to read the code—to be
able to predict variation in gene expression levels based on the
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nucleotide sequence—and this goal remains challenging. The
main difficulty is that many changes in TF binding do not seem to
result in measurable changes in gene expression levels, and we do
not yet know how to distinguish between binding events that affect
gene expression and those that do not [55]. Perhaps much of TF
binding is not directly functional, or maybe the marginal effects of
a change in binding of one TF are too small to detect given the
complexity of interactions between different regulatory mecha-
nisms.
For example, Cusanovich and colleagues [55] attempted to
characterize functional TF binding by characterizing genome-
wide gene expression profiles following the independent knock-
downs of 59 TFs in the same lymphoblastoid cell line. Depending
on which TF was knocked down, the expression levels of a few
Fig. 3. A representative example of a QTL in a TF binding site correlated with changes across multiple regulatory mechanisms.Many
concerted changes in regulatory mechanisms across genotypes can be linked to a sequence change in transcription factor binding sites, which might
causally influence downstream changes. (A) For TFs that regulate concerted changes in transcriptional marks, SNPs that cause a large change in
binding affinity (as measured by a position weight matrix score, x-axes) might also show a large skew in the ratio of transcription mark reads from
each allele (measured as fraction of reads from the reference allele, y-axes). Evidence for this correlation across all SNPs in binding sites (top panel, red
points) implies a relationship between TF binding and the transcriptional mark. Significant correlations can then be assessed for a given TF across
multiple transcriptional marks (bottom panel, where each line represents a correlation using allelic biases measured from different histone
modifications, PolII localization, etc.) to understand which mechanisms might be influenced by changes in binding of the given TF. (B) Overall,
looking at allelic biases in transcriptional marks at SNPs that can affect TF binding affinity show a pattern whereby increased TF binding is promoting
open chromatin (measured by DNaseI sensitivity), nucleosome positioning, and enrichment of activating histone modifications relative to sites with
weaker TF binding. Importantly, since SNPs in these binding sites usually only have moderate-to-weak effects on binding affinity, QTL SNPs most
likely serve to shift the equilibrium frequencies between these two configurations within populations of cells. (C) This example of a TF binding QTL
shows a SNP, rs2886870, that falls within a binding site for the NF-kB transcription factor. NF-kB ChIP-seq data [17] show that LCLs with at least one T
allele (TG genotype; purple) matching the consensus motif sequence [63] have higher NF-kB binding than LCLs with no T alleles (GG genotype;
orange). The top panel shows the distribution of ChIP-seq reads in a 500-bp window around rs2886870, with the grey line representing the mean
across four individuals and the colored outlines representing the 95% confidence intervals. The rs2886870 SNP also acts as a QTL for several
downstream regulatory patterns, with the T allele promoting significantly increased DNaseI hypersensitivity, PolII localization, and H3K7ac marks at
the site of the transcription factor site and increased PolII localization, H3K4me3 marks, and H3K7ac marks at the promoter of the downstream
C3orf59 gene, whose expression is also significantly associated with this QTL (panel reproduced from McVicker et al. 2013 [25]).
doi:10.1371/journal.pgen.1004857.g003
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dozen to several thousands of genes were significantly perturbed.
However, in all cases, only a small subset of genes inferred to be
bound by any individual TF were differentially expressed following
the knockdown of that factor [55]. This observation suggests that
many instances of TF binding in the genome do not result in
measurable changes in gene expression levels of the putative target
genes.
Regardless of the logic of functional TF binding, while
transcriptional regulation at promoters and enhancers outweigh
known posttranscriptional effects, it is clear that not all regulation
is happening within promoter regions. Along these lines, many
interesting nonintuitive interactions between regulatory elements
have emerged from regQTL studies. For instance, both sQTLs
and rdQTLs, which are primarily enriched within canonical splice
site motifs and 39 UTR stability motifs, respectively, also have
strong signals at the transcription start site and seem to be
cooperatively regulating gene expression variation with transcrip-
tional mechanisms [30,36]. These observations highlight the fact
that none of these mechanisms work in isolation and complex
coregulatory phenomena are quite common, if likely situation
dependent. Similarly, though regQTL studies have advanced our
understanding of the mechanistic basis for many eQTLs, there
remain many regQTLs that seem to have no discernable effect on
gene expression phenotypes [19,21,30]—for instance, while 55%
of eQTL SNPs are identified as dsQTLs, only 39% of all dsQTLs
are also associated with changes in gene expression levels [19].
Combined studies of quantitative posttranscriptional and protein
measurements might provide insight into many of these non-
eQTL regQTLs, but overall, the functional consequences of these
unexplained regQTLs remains an unanswered question in the
field.
What Have We Learned and What’s Next?
While recent work analyzing combinations of functional
genomic data types has taught us much about the principles of
gene regulatory logic, the results have more importantly opened
the door for new sets of questions to be addressed. Theoretical
models of gene regulatory networks and logic can finally be tested
and refined based on directly relevant genomic data of high
resolution and incredible breadth and depth. Outstanding
questions about causality, the order of regulatory events, and the
direction of effects can finally be addressed. For instance, the initial
intuition that histone modifications regulate chromatin state,
which in turn determine whether factors can bind to different sites,
might generally be inaccurate [24,25,56]. Instead, TF binding
seems to be the central event that mediates concerted changes in
other regulatory mechanisms determining chromatin states,
accessibility, and conformations. This, however, cannot be an
exclusive statement because it would require that the entire system
rely entirely on the variation in TF expression. An intermediate
model has been suggested, by which a small number of particular
TF, at a subset of their designated binding sites, can act as pioneer
factors. Pioneer activity generates concerted changes in chromatin
state, which are maintained by histone marks, DNA methylation,
and nucleosome positioning [57–59]. Chromatin areas that are
accessible because of pioneer activity are available for binding by
secondary factors [57,58]. Though direct evidence for the model
of pioneer transcription factors is still weak, the model is consistent
with all of the genomic variation data collected to date.
One promising way to move forward is by considering a
combination of data across individuals and across tissue types (for
example, the Genotype-Tissue Expression [GTEx] study). While
the genetic and mechanistic basis for regulatory variation across
individuals is of great interest, one of the factors limiting the utility
of population data is that relatively modest regulatory difference
are observed between individuals. Regulatory differences between
tissues or different cell types are of a much larger magnitude.
Moreover, while the regulatory landscape in the same cell type or
tissue across individuals is highly similar (with the occasional
difference due to genetic or epigenetic variation), the regulatory
programs in different cell types can be vastly different. It is thus
expected that a combined analysis of regulatory variation between
individuals and across tissues may have more power to detect
partial correlations and thus infer causality.
With a better understanding of the cascade of regulatory events
that leads to variation in gene expression outputs, we can turn our
attention back to the persistent questions that motivate much of
the research in the fields of regulatory evolution and disease
susceptibility. What are the modes of evolution within species?
How many regulatory changes underlie a phenotypic adaptation
and what mechanisms are affected? What are the most important
genetic changes in the evolution of particular lineages?
The genomic tools that allow us to collect appropriate data with
which to address these questions are already largely available. For
example, it is now possible to perform genome editing of specific
loci in order to specifically test the causal role of individual
nucleotide changes. Yet, in humans—where direct manipulation
of the entire individual is not possible—a suitable and faithful
cellular system is needed in order to carry out such experiments.
Studies using the LCL system in humans have yielded a wealth of
information and insight as we considered steady-state regulatory
phenotypes, but it seems that we have nearly exhausted the
usefulness of this artificial system, which does not lend itself well to
temporal, developmental, or spatial variation in gene regulation.
New systems, such as induced pluripotent cells (iPSC) and their
derived differentiated cell types, are perhaps a more appropriate
and fertile resource for such studies [60–62].
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